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Background: Transradial approach (TRA) for percutaneous coronary interventions (PCI) has been performed since 1994. Despite lower risks of 
access-site related complications compared to the femoral approach (FA), the clinical benefit of TRA is uncertain. We undertook a systematic review 
and meta-analysis comparing TRA and FA for PCI.
Methods: A literature search aimed at identifying all clinical trials and observational studies comparing TRA with FA for PCI with reports of clinical 
outcomes was performed. Odds ratios (OR) were estimated by a hierarchical Bayesian random-effects model with prespecified stratification for 
observational and randomized designs. The primary outcomes examined were rates of death, combined incidence of death or myocardial infarction 
(MI), bleeding and transfusions, early (≤ 30 days) and late after PCI.
Results: We collected data from 73 studies (14 randomized, 59 observational) involving a total of 1,022,123 patients. There was a strong 
association between TRA and mortality early after intervention (OR 0.52, 95% credible interval (CrI) 0.43-0.62), although the effect was mainly due 
to observational studies (OR 0.49, 95% CrI 0.39-0.59), with an OR 0.74 (95% CrI 0.38-1.40) in randomized trials. An association between TRA and 
death or MI was observed over short-term follow-up (OR 0.66, 95% CrI 0.51-0.82), with an OR of 0.72 (95% CrI 0.41-1.14) for long-term follow-up. 
Compared with FA, TRA was associated with a major reduction in bleeding (OR 0.22, 95% CrI 0.16-0.29) and in transfusions (OR 0.20, 95% CrI 0.10-
0.31). These findings were consistent in both randomized and observational studies.
Conclusions: Our results suggest that PCI performed by TRA is associated with lower risks of death, death or MI, bleeding and transfusions 
when compared to FA. While an adequately powered randomized trial for ischemic and bleeding outcomes is required to definitively establish 
the superiority of TRA over FA for PCI, our results suggest that greater adoption of TRA has the potential to substantially improve outcomes among 
patients undergoing PCI.
